BMY 14802 is a sigma-1 receptor (sigma1R) antagonist, as well as an agonist at serotonin (5-HT) 1A and adrenergic alpha-1 receptors. BMY 14802 inhibits abnormal involuntary movement (AIM) in rat Parkinsons disease (PD) model, with down-regulating the expression of AIM[1][2].
Molecular Weight:
348.39
Purity:
98.96
CAS Number:
[105565-56-8]
Formula:
C18H22F2N4O
Target:
5-HT Receptor,Adrenergic Receptor,Sigma Receptor
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted